April 20, 2009

AHRP Letter to Harvard Re: Dr. Biederman’s Research

ALLIANCE FOR HUMAN RESEARCH PROTECTION A catalyst for public debate 142 West End Avenue Suite 28P New

Read More
AHRP Letter to Harvard Re: Dr. Biederman’s Research

March 20, 2007

The Damaging Impact of PDUFA and Why It Should be Repealed

The prescription drug user fee act (PDUFA, 1992), which is up for renewalthis year, linked the Food

Read More
The Damaging Impact of PDUFA and Why It Should be Repealed

February 13, 2007

Court Ruling: Injunction on Release of Zyprexa Documents

The documents contain evidence of Lilly’s marketing strategy promoting Zyprexa for unapproved, off-label uses while concealing from doctors

Read More
Court Ruling: Injunction on Release of Zyprexa Documents

February 6, 2007

Pharma Spin and Child Suicide Rates

According to the Center for Disease Control and Prevention’s Annual Summary of Vital Statistics, the suicide rate

Read More
Pharma Spin and Child Suicide Rates

January 22, 2007

Role of Litigation in Defining Drug Risks_JAMA / BMJ

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Read More
Role of Litigation in Defining Drug Risks_JAMA / BMJ

January 21, 2007

Are Lipid lowering (Statins) Guidelines Evidence-Based? Lancet

A Commentary in the Lancet by John Abramson, MD, of Harvard Medical School, author of Overdosed America,

Read More
Are Lipid lowering (Statins) Guidelines Evidence-Based? Lancet

December 11, 2006

Critique of FDA’s latest SSRI Data Analysis

The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)Promoting Openness, Full Disclosure, and Accountabilitywww.ahrp.org PRESS BRIEFING Bullet points: Critique

Read More
Critique of FDA’s latest SSRI Data Analysis

December 1, 2006

New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

The second phase of the government study, Clinical Antipsychotic Trials inIntervention Effectiveness (CATIE), was released and the

Read More
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

November 26, 2006

Negative Research Results–Mostly Concealed in Journals_SharonBegley, WSJ

A recent engaging column by Sharon Begley, Wall Street Journal (below), underscores the importance of publishing both

Read More
Negative Research Results–Mostly Concealed in Journals_SharonBegley, WSJ

October 3, 2006

Antipsychotics, Newer Isn’t BetterDrug_Washington Post front page

Shankar Vedantam of The Washington Post reports (below) “a study published yesterday overturns conventional wisdom about antipsychotic drugs,

Read More
Antipsychotics, Newer Isn’t BetterDrug_Washington Post front page

September 30, 2006

Pediatric Cardiologist Explains: The crucial health stat you’ve never heard of_Slate

An article by pediatric cardiologist, Dr. Darshak Sanghavi, the author of “A Map of the Child: A

Read More
Pediatric Cardiologist Explains: The crucial health stat you’ve never heard of_Slate

August 25, 2006

Marketing Suicide by Misapplying Population Trends_No Competing Interests?

Neither aggregate suicide rates nor the individuals who commit suicide, are predictable, and no intervention has ever

Read More
Marketing Suicide by Misapplying Population Trends_No Competing Interests?